• About ArQule
• Product R & D
• Clinical Trials
• Investors and Media
  • Press Releases
  • Events
  • Corporate Presentation
  • Recent Data Presentations
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Contact Us
• Careers

Recent Data Presentations

AACR-NCI-EORTC - November 2011

AACR-NCI-EORTC   1.1 MB

ASCO - June 2011

Sorafenib combo ASCO 2011 Poster 395.4 KB   Gem combo ASCO 2011 Poster  1.2 MB   CRC ASCO 2011 Poster 983.6 KB   Germ cell tumors ASCO 2011 Poster 659.2 KB   Phase 3 NSCLC in progress ASCO 11 Poster 638.5 KB   ARQ 621 ASCO 2011 684.7 KB

ASCO 2011 Gastrointestinal Cancers Symposium - January 2011

Phase 1 Results of the Phase 1/2 Study of ARQ 197, Irinotecan and Cetuximab in Patients with Colorectal   1.1 MB

2010 Chicago Multidisciplinary Symposium in Thoracic Oncology - December 2010

Results from ARQ 197-209 417.9 KB

European Society for Medical Oncology - October 2010

ARQ197_ESMO 2010 444.7 KB   ARQ197-114_ESMO Poster 196  1.8 MB   ARQ197-116_ESMO Poster 509  4.1 MB   ARQ197-117_ESMO Poster 510  4.1 MB

ASCO - June 2010

ARQ197-209 ASCO Poster  1.2 MB   116 ASCO Poster 580.7 KB   ARQ 197-114 ASCO Poster 353.0 KB   ARQ 197-215 ASCO Poster 345.5 KB

2010 Gastrointestinal Cancers Symposium - January 2010

A Phase 1b Safety Study of ARQ 197 in Cirrhotic Patients with Hepatocellular Carcinoma (ARQ 197-114)  2.2 MB

The 13th World Lung Conference - August 2009

Phase 1 Dose Escalation Trial (ARQ197-111) Evaluating Combination of Selective c-MET Inhibitor ARQ 197 and Erlotinib  1.8 MB

ASCO - June 2009

Phase 1 Dose Escalation Trial (ARQ 197-111) Evaluating Combination of Selective c-MET Inhibitor ARQ 197 and Erlotinib 179.7 KB   Final Results: A Dose Escalation Phase 1 Study of ARQ 197, a Selective c-MET Inhibitor, in Patients with Metastatic Solid Tumors 494.4 KB   Preliminary Results from a Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transcription Factor Family (MiT) Associated Tumors  1.0 MB   Final Results of a Pharmacokinetic and Pharmacodynamic Phase I Trial of ARQ 197 946.4 KB

= add file to Briefcase